Skip to content

Janux Therapeutics JANX Investment Purchases

Investment Purchases at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$144M-42.6%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$20.14M-84.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$452.25M+1,714%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$177.29M
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$139.09M+138,993%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$158.37M-8.8%

Other financials

Income statement

See full
Revenue$3.7M
Operating income-$34.2M+2.0%
Net income-$24.4M-3.6%
EPS (diluted)-$0.39-2.6%

Balance sheet

See full
Cash & equivalents$51.8M-29.7%
Total debt$21.6M-4.6%
Total equity$941.5M-7.0%
Total assets$1.0B-2.1%

Cash flow

See full
Operating cash flow-$12.3M+27.5%
CapEx$273.0K-26.4%
Free cash flow-$12.6M+27.5%

Valuation

See full
Market cap$892.81M-36.1%
Enterprise value$862.55M-35.9%
P/S65×-84.6×

Profitability

See full
Operating margin-1,143.1%-65.1pp
Net margin-833.6%+0.9pp
FCF margin-571.6%+98.3pp

Returns & leverage

See full
Return on equity-11.7%+4.1pp
Debt / equity0.0×
Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janux Therapeutics's investment purchases?
Janux Therapeutics (JANX) reported investment purchases of $112.75M in Q1 2026.
How has Janux Therapeutics's investment purchases changed year-over-year?
Janux Therapeutics's investment purchases decreased by 69.6% year-over-year, from $371.29M to $112.75M.
What is the long-term trend for Janux Therapeutics's investment purchases?
Over 4 years (2021 to 2025), Janux Therapeutics's investment purchases has grown at a 10.5% compound annual growth rate (CAGR), from $473.63M to $705.22M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.